CTNM · CIK 0001855175 · operating
Contineum Therapeutics, Inc. (CTNM) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $560 million, Contineum Therapeutics, Inc. is a small-cap company. The stock currently trades at $15.34, up 0.00% today, with a 52-week range of $3.35–$16.33.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-2.18 | $-2.18 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-06 | 0001437749-25-006458 | SEC ↗ |